Products for Research Use Only
RegisterLogin

JWJ-01-378

CAT: 0804-HY-175271Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175271Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JWJ-01-378 is a selective TRK PROTAC degrader. JWJ-01-378 efficiently degrades WT TRK and TPM3-TRKA fusion proteins and inhibits downstream pERK signaling, while showing limited efficacy against TRK inhibitor resistant mutants and ALK fusions. JWJ-01-378 potently suppresses cancer cell proliferation[1].Pink: TRK ligand ; Blue: CRBN ligase ligand (HY-103596) ; Black: linker
UNSPSC
12352005
Target
ERK; PROTACs; Trk Receptor
Related Pathways
MAPK/ERK Pathway; Neuronal Signaling; PROTAC; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(NCCCCCCCCNC(CN1CCN(CC1)C2=CC(NC3CCOCC3)=C(C=C2)C(NC4=NNC5=C4C=C(C=C5)CC6=CC(F)=CC(F)=C6)=O)=O)COC7=C8C(N(C(C8=CC=C7)=O)C9CCC(NC9=O)=O)=O
Molecular Formula
C55H62F2N10O9
Molecular Weight
1045.14
References & Citations
[1]Kumar S, et al. Development of PROTACs for targeted degradation of oncogenic TRK fusions. bioRxiv [Preprint]. 2025 Jun 24:2025.06.18.660465.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-161767-01JWJ-01-306
HY-124341ND-378
HY-P2452-01Vitronectin (367-378)
HY-W953035CRBN ligand-378
HY-P5911-01GluN1 (359-378)
HY-122209DVR-01
HY-137464A-01OATD-01
HY-161768VCC972839:01
HY-106839NKS-01
HY-155870DL-01

Alternative Products

CatalogName
GTR19264723-01JWJ-01-378
GTR19262919-01JWJ-01-306
T28147-01ND-378
B1928-5LDK-378
MZIP378-PA-1miRZip-378 anti-miR-378 microRNA construct
T38603-01Vitronectin (367-378)
BIPG1997-01BP Lipid 378
GTR19034830-01GluN1 (359-378)
C07755-10mgLopinavir (ABT-378)
MBS132292-01Lopinavir, ABT 378

Popular Products